Published on in CHOP News
CHOP researchers have found that NTRK fusions are more common than expected in pediatric tumors, which could lead to better screening and treatment.
Published on in CHOP News, Cancer Connections
The FDA has approved a treatment that targets ALK mutations in relapsed, refractory ALK-positive anaplastic large cell lymphoma.
Published on in CHOP News
A Phase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain.
Published on in CHOP News
CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.
Published on in CHOP News
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Published on in CHOP News
Grant awarded to CHOP and Gustave Roussy to support phase 3 clinical trial developed by Children’s Oncology Group and International Society of Paediatric Oncology Europe Neuroblastoma Group, representing first-ever collaboration between North American and European neuroblastoma consortia.
Published on in CHOP News
Read this case study about a patient who received treatment for osterosarcoma and underwent limb salvage surgery at Children’s Hospital of Philadelphia.
Published on in CHOP News
Nine CHOP clinicians and researchers made presentations at SIOP 2020.
Published on in CHOP News
New therapy shrinks tumors associated with NF1 and improves quality of life.
Published on in CHOP News
Using genetic sequencing and targeted treatment, CHOP researchers resolved a severe lymphatic disorder in a young woman with KLA, a complex and rare disorder.